Stock Notes

Aurobindo Pharma

Every Finvezto stock note on Aurobindo Pharma, dated and newest first. Coverage spans pharma.

1 note and counting
04 Jun 2026
Aurobindo Pharma received final US FDA approval for Tofacitinib tablets in 5 mg and 10 mg strengths, the generic of Pfizer's Xeljanz.
Tofacitinib treats rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, adding to Aurobindo's 550-plus final US approvals that anchor its largest revenue market.

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.